Quayle Council's Plans for Changing FDA's Drug Approval Process : A Prescription for Harm.
| Corporate Authors: | United States. Congress. House. Committee on Government Operations, ProQuest (Firm), United States. Congress. House |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Washington :
[publisher not identified],
1992.
|
| Series: | United States congressional serial set.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Similar Items
FDA's Regulation of the New Drug Merital.
Published: (1987)
Published: (1987)
Prescription for Harm : The Decline in FDA Enforcement Activity.
Published: (2006)
Published: (2006)
FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)
Published: (1989)
Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.
Published: (1993)
Published: (1993)
Investigation of Drug Safety.
Published: (1964)
Published: (1964)
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)
Published: (2005)
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)
Published: (2005)
FDA and Fresh Spinach Safety.
Published: (2008)
Published: (2008)
The FDA prescription drug file.
Published: (1991)
Published: (1991)
Amending section 8 of the Pure Food and Drugs Act.
Published: (1919)
Published: (1919)
FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)
Published: (1995)
Drugs@FDA.
National Drug Policy Board : A Failure in the War on Drugs.
Published: (1987)
Published: (1987)
FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)
Published: (2003)
FDA approved animal drug products.
FDA approved animal drug products.
FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)
Published: (2002)
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)
Published: (1989)
List of FDA approved animal drug products /
Published: (1987)
Published: (1987)
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)
Published: (1989)
FDA drug approval : application review times largely reflect FDA goals : report to congressional requesters.
Published: (2020)
Published: (2020)
Juvenile delinquency.
Published: (1953)
Published: (1953)
Letter from the Secretary of Agriculture, transmitting, in response to the Resolution of the Senate of April 6, 1904, a report by the Chief of the Bureau of Chemistry covering all investigations of adulterated foods, drugs, and liquors made under the provisions of paragraph 2 of the Act of March 1, 1899.
Published: (1904)
Published: (1904)
FDA drug bulletin.
Published: (1971)
Published: (1971)
FDA's review process for new drug applications : a management review.
Published: (2003)
Published: (2003)
International investigation of opium evil. Message from the President of the United States, transmitting a letter from the Secretary of State recommending an appropriation for the participation of the United States in the coming investigation of the opium question in the Far East by a joint international commission.
Published: (1908)
Published: (1908)
Bush-Quayle : the Reagan legacy /
by: Ide, Arthur Frederick
Published: (1989)
by: Ide, Arthur Frederick
Published: (1989)
FDA's Technology Modernization Action Plan (TMAP).
Published: (2019)
Published: (2019)
FDA's drug review process and the package label : strategies for writing successful FDA submissions /
by: Brody, Tom
Published: (2017)
by: Brody, Tom
Published: (2017)
Antitrust Concerns and the FDA Approval Process.
Published: (2017)
Published: (2017)
Animal drugs @ FDA.
Discussion of FDA priorities : fiscal year 1987 planning process, March 1985.
Published: (1985)
Published: (1985)
Preparing for FDA pre-approval inspections /
Published: (1999)
Published: (1999)
Food and Drug Administration : improved monitoring and development of performance measures needed to strengthen oversight of criminal and misconduct investigations : report to the Ranking Member, Committee on Finance, U.S. Senate.
Published: (2010)
Published: (2010)
Nuclear Regulation Reorganization and Reform Act of 1988.
Published: (1988)
Published: (1988)
Independent Safety Board Act of 1974 Amendments Act of 1990.
Published: (1990)
Published: (1990)
How FDA approves drugs and regulates their safety and effectiveness /
by: Dabrowska, Agata
Published: (2018)
by: Dabrowska, Agata
Published: (2018)
Military use of drugs not yet approved by the FDA for CW/BW defense : lessons from the Gulf War /
by: Rettig, Richard A.
Published: (1999)
by: Rettig, Richard A.
Published: (1999)
FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)
Published: (1992)
FDA investigations operations manual /
Published: (1994)
Published: (1994)